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VASCULAR SMOOTH MUSCLE SIRTUIN-1 PROTECTS AGAINST AORTIC 
DISSECTION DURING ANGIOTENSIN II–INDUCED HYPERTENSION 
RACHID AKIKI 
ABSTRACT 
 Background-—Sirtuin-1 (SirT1), a nicotinamide adenine dinucleotide+ –
dependent deacetylase, is a key enzyme in the cellular response to metabolic, 
inflammatory, and oxidative stresses; however, the role of endogenous SirT1 in the 
vasculature has not been fully elucidated. Our goal was to evaluate the role of vascular 
smooth muscle SirT1 in the physiological response of the aortic wall to angiotensin II, a 
potent hypertrophic, oxidant, and inflammatory stimulus.  
 
Methods and Results-—Mice lacking SirT1 in vascular smooth muscle (ie, smooth 
muscle SirT1 knockout) had drastically high mortality (70%) caused by aortic dissection 
after angiotensin II infusion (1 mg/kg per day) but not after an equipotent dose of 
norepinephrine, despite comparable blood pressure increases. Smooth muscle SirT1 
knockout mice did not show any abnormal aortic morphology or blood pressure 
compared with wild-type littermates. Nonetheless, in response to angiotensin II, aortas 
from smooth muscle SirT1 knockout mice had severely disorganized elastic lamellae 
with frequent elastin breaks, increased oxidant production, and aortic stiffness compared 
with angiotensin II–treated wild-type mice. Matrix metalloproteinase expression and 
activity were increased in the aortas of angiotensin II–treated smooth muscle SirT1 
knockout mice and were prevented in mice overexpressing SirT1 in vascular smooth 
		 vi 
muscle or with use of the oxidant scavenger tempol.  
 
Conclusions-—Endogenous SirT1 in aortic smooth muscle is required to maintain the 
structural integrity of the aortic wall in response to oxidant and inflammatory stimuli, at 
least in part, by suppressing oxidant-induced matrix metalloproteinase activity. SirT1 
activators could potentially be a novel therapeutic approach to prevent aortic dissection 
and rupture in patients at risk, such as those with hypertension or genetic disorders, such 
as Marfan’s syndrome. 
. 
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Introduction 
The walls of large arteries are composed of 3 cell types: endothelial cells, vascular 
smooth muscle (VSM) cells, and adventitial fibroblasts. Together with their underlying 
extracellular matrix, these cells form an intricate network that responds dynamically to 
hemodynamic changes and vasoactive factors. Among these, angiotensin II (AngII), a 
peptide hormone of the renin–angiotensin–aldosterone system, elicits pleiotropic effects 
on the vasculature. AngII is a potent vasoconstrictor signaling primarily through AngII 
receptor type 1 (AT1R) to constrict resistance vessels and maintain blood pressure in 
response to hypovolemia and increased renin. In addition, AngII can elicit inflammation 
and remodeling of the aortic wall via generation of reactive oxygen species (ROS), 
through activation of NADPH oxidases, and by production of transforming growth factor 
b—responses that are independent of AngII vasopressor effect on resistance vessels.1 
These combined signals produce a phenotypic switch in the media and adventitia that 
results in medial hypertrophy and collagen deposition, profoundly affecting the 
mechanical properties of the aorta.2,3 ROS production in the aorta is increased in aging, 
diabetes, and chronic inflammation—conditions associated with activation of the renin–
angiotensin–aldosterone system—and it contributes significantly to the pathogenesis of 
aortic diseases. In settings of increased endothelium-derived ROS, moderate doses of 
AngII (1 mg/kg per day) are sufficient to stimulate an inflammatory response in the 
murine aorta, which activates elastin degradation by matrix metalloproteinases (MMPs) 
in VSM, leading to aortic dissection.4 Sirtuin-1 (SirT1; mammalian homolog of silent 
information regulator in yeast) is a nicotinamide adenine dinucleotide+ – dependent 
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deacetylase and a molecular target of polyphenols and calorie restriction.5 SirT1 is 
generally associated with beneficial metabolic effects6 by virtue of antioxidant 7,8 and 
anti-inflammatory9 effects; however, the role of SirT1 in the vasculature is not fully 
elucidated. SirT1 deacetylates and alters the function of key molecules involved in 
vascular homeostasis; therefore, loss of SirT1 activity may be detrimental to the 
vasculature. Lack of SirT1 in VSM in apolipoprotein E–deficient mice exacerbates 
atherosclerosis,10 whereas VSM SirT1–overexpressing mice are resistant to neointima 
formation in response to carotid artery ligation.11 VSM SirT1 overexpression ameliorates 
medial hypertrophy in a model of AngII hypertension, concomitant with a decrease in 
inflammation, via inhibition of nuclear factor jB and transforming growth factor b. 12 
Because SirT1 is an attractive pharmaceutical target, it is crucial to elucidate the role of 
endogenous SirT1 and downstream signals in the vasculature. To this end, we created a 
mutant mouse bearing a SirT1 deletion in VSM, the major component of large elastic 
arteries (smooth muscle SirT1 knockout [SMKO] mice). In this study, we report that lack 
of VSM SirT1 results in high incidence of aortic dissection in response to AngII-induced 
hypertension. SMKO mice have baseline and blood pressure responses to a-adrenergic 
agonists comparable to wild-type (WT) littermates, and during a short course of AngII (1 
mg/kg per day), they become hypertensive, although to a lesser extent than their WT 
counterparts. At baseline, vessel walls lacking SirT1 in VSM have normal elastin 
structure and aortic compliance; however, they display severely deranged elastic fibers, 
increased MMP activity, and stiffness on exposure to AngII, and 70% of SMKO mice die 
of aortic dissection within 14 days. Taken together, these data demonstrate a crucial role 
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of VSM SirT1 in the maintenance of vascular wall integrity in response to AngII and 
provide a unique model of aortic dissection. 
 
Materials and Methods  
VSM SMKO Mice 
All animal experimental procedures were approved by the institutional animal care and 
use committee at Boston University Medical Campus. Floxed SirT1 mice on a C57Bl/ 6J 
genetic background in which 2 loxP sites flank SirT1 exon 4, a critical exon required for 
the enzyme catalytic activity, were obtained from David Sinclair at Harvard University 
(Cambridge, MA). Floxed SirT1ex4 mice were bred with a Crerecombinase transgenic 
mouse in which Cre-recombinase expression is driven by the endogenous smooth muscle 
22a protein (SM22a; transgelin) promoter (endogenous locus SM22a Cre Knock-In; 
B6.129S6 Taglntm2(cre)Yec/J; Jackson Laboratories), generating a mouse with SirT1 
exon 4 deletion in VSM (SMKO). Similarly, mice overexpressing SirT1 in VSM, 
(SMTg), were generated by intercrossing a transgenic mouse in which the SirT1 gene is 
inserted downstream of the collagen type I locus and preceded by loxP sites flanking a 
stop codon (obtained from David Sinclair), with the SM22aCre male mice described 
above. Cre-recombinase activity in VSM cells removes the stop codon, allowing 
overexpression of the SirT1 gene. To confirm the specificity of SirT1 deletion or 
overexpression for the VSM, we intercrossed SM22a-Cre with Tomato reporter mice 
(B6.Cg-Gt[ROSA]26Sortm9[CAG-tdTomato]Hze/ J; Jackson Laboratories). A 
fluorescently red Tomato protein is constitutively expressed except in cells containing 
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Cre recombinase, in which enhanced green fluorescent protein is expressed instead of red 
Tomato on removal of a stop codon by the Cre-recombinase activity. Mice were housed 
in the Boston University Laboratory Animal Science Center in 12-hour light/dark-cycle 
rooms and with food and water ad libidum.  
 
AngII-Induced Hypertension  
WT, SMKO, and SMTg mice aged 8 weeks were implanted subcutaneously with Alzet 
osmotic minipumps (model 1007D or 1002 for 1 or 2 weeks of infusion, respectively) 
containing 1 mg/kg per day of AngII (item A9525; Sigma-Aldrich) dissolved in 100 lL 
saline or 10 mg/kg per day of norepinephrine (Sigma-Aldrich) dissolved in 100 lL saline 
containing 1 mmol/L ascorbate. The occurrence of deaths and/or aortic dissections and 
overall animal health were closely monitored and recorded during AngII or 
norepinephrine administration. The development of hypertension in response to AngII or 
norepinephrine infusion was monitored by radiotelemetry (Data Sciences International) 
in conscious, freely moving WT (n=5) and SMKO (n=5) mice. Radiotelemetry hardware 
included the Data Exchange Matrix, PhysioTel receivers (RCP-1), and a calibrated 
ambient pressure reference monitor (APR-1). Implantation of the wireless transmitters 
was performed in sterile conditions, following the manufacturer’s recommendations. 
Briefly, the pressure-sensing region (4 mm) of the catheter (model TA11PA-C10) was 
situated in the aortic arch via catheterization of the left carotid artery in isofluorane-
anesthetized mice, and the transmitter body was placed in a subcutaneous pocket in the 
right flank. Recordings (1 every 4 minutes, 360 recordings per mouse per day) started 
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after complete recovery from surgery (1 to 2 weeks). Data are expressed as meanSEM 
after averaging 360 recordings per day for each mouse.  
 
Arterial Pressures and Stiffness Measured by High-Fidelity Pressure Catheters  
In addition to radiotelemetry, mean arterial pressure was assessed in anesthetized WT and 
SMKO mice using a solidstate high-fidelity pressure catheter (Mikro-tip catheter 
transducers, SPR-1000; Millar Instruments) inserted in the carotid artery. Ten minutes of 
stable pressure waveforms were recorded at baseline and after a bolus administration of 
phenylephrine (0.1 lg/g of body weight), through a P10 polyurethane tapered catheter 
(FunnelCath; Harvard Apparatus) inserted in the right jugular vein. Pulse wave velocity, 
the standard in vivo measure of arterial stiffness, was assessed by simultaneously 
recording blood pressure waveforms from 2 locations along the aorta. We used a dual-
pressure catheter (1.4 French) interfaced with an acquisition and analysis workstation 
(NIHem; Cardiovascular Engineering) with 1 kHz of bandwidth and a 5-kHz sampling 
rate. Briefly, saline- or AngII-treated mice were deeply anesthetized with a ketamine–
xylazine mixture and kept recumbent on a heated pad (38°C). ECG was acquired through 
needle electrodes with lead wires connected to an acquisition system (PowerLab Animal 
BioAmp; ADInstruments). The catheter was inserted in the left carotid artery and then 
gently advanced into the aorta so that the first pressure-sensing region was situated into 
the aortic arch (proximal location) and the second 2.5 cm distally to obtain stable 
pressure waveform recordings from both locations simultaneously. The foot-to-foot 
transit time was assessed automatically from signal-averaged proximal and distal pressure 
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waveforms over 20-second continuous recording using the R-wave of ECG as a fiducial 
point and resynchronization of sequential recordings (NIHem software v. 4.99; 
Cardiovascular Engineering). Pulse wave velocity was then calculated by dividing the 
distance (2.5 cm) by the difference among the 2 arrival times (in milliseconds). A total of 
21 pulse wave velocity measurements were performed as follows: 4 in WT saline-treated 
mice (WT/saline), 4 in SMKO saline-treated mice (SMKO/saline), 5 in WT AngII-treated 
mice (WT/AngII), and 8 in SMKO AngII-treated mice (SMKO/AngII). One AngII-
treated WT mouse died during surgery, and 4 AngII-treated SMKO mice presented with 
aortic dissection at necropsy and thus were excluded from further analysis. Pressure 
recordings from surviving and nondissected mice (n=4 in each group) were analyzed and 
computed in the group average.  
 
Mechanical Properties of the Aorta (Ex Vivo Stiffness Measurement) 
 Stiffness of thoracic aortas was assessed in nondissected, viable aortic rings from saline- 
and AngII-treated WT and SMKO mice (n=4, WT/saline; n=4, SMKO/saline; n=5, WT/ 
AngII; n=5, SMKO/AngII). High-frequency, low-amplitude length oscillations, which 
have negligible effects on the function of the aortic rings, were used to assess ex vivo 
stiffness, as described previously.13  
 
Aortic Morphometry and Immunostaining  
Adjacent thoracic aortic rings were incubated for 30 minutes in nuclear stain (NucBlue; 
Life Technologies) and then captured with a fluorescent microscope, together with 
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autofluorescence of elastin lamellae (NIS-Elements software; Nikon). A total of 15 to 20 
measurements of the medial thickness (distance between external and internal elastic 
lamina) and diameter from 3 rings for each mouse were averaged before calculating the 
mean of each experimental group (n=8, WT/saline; n=7, SMKO/saline; n=10, WT/AngII; 
n=7, SMKO/AngII). Aortas from saline- or AngII-treated WT and SMKO mice were 
snap-frozen in optimal cutting temperature compound and sectioned on a cryotome at a 
thickness of 6 µm. To evaluate elastin, aortic sections from the aortic root to the 
infrarenal aorta for each mouse were stained using an elastin staining kit (Accustain 
Elastin Stain; Sigma-Aldrich), based on the Van Gieson methodology, and were 
qualitatively analyzed in a blinded fashion by Dr Josenia Tan at Boston University 
School of Medicine, Department of Pathology. 
 
 Multiphoton Microscopy for Label-Free Imaging of Elastin Fibers 
 Elastin possesses an intrinsic 2-photon fluorescence that enables label-free imaging in 
intact tissue.14–16 Freshly excised aorta from saline- and AngII-treated WT and SMKO 
mice (n=4, WT/saline; n=4, SMKO/saline; n=5, WT/AngII; n=5, SMKO/AngII) were 
imaged on a custom-built multiphoton scanning microscope. Aortas were submerged in 
PBS on a glass slide, and a coverslip was placed on top. Spacers were present on both 
sides of arteries to ensure they would not be deformed by the coverslip. The 2-photon 
autofluorescence signal from elastin was detected at 525/ 45 nm and generated with 65 
mW of a mode-locked Ti: sapphire laser at 800 nm (Maitai-HP; Spectra-Physics). 
Second-harmonic generation from collagen at 400 nm (417/80 nm) was also collected. 
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Samples were imaged at 3 locations over the length of the descending aorta. Images were 
recorded at every 2 lm through the arterial thickness. 
Elastin images were analyzed using the Directionality plug-in in the imaging 
processing software FIJI (freely available at www.nih.gov). This plug-in performs a 
Fourier component analysis to evaluate the dispersion of the elastin signal, as described 
in detail elsewhere.17,18 The dispersion represents the variation in fiber orientation; 
therefore, an increase in dispersion indicates a decrease in organization. Eight regions of 
32932 lm having a unique main orientation were analyzed per artery. The dispersion 
value, in degrees, was normalized to the amount of fiber present in the analyzed region, 
another output of the Directionality plug-in.  
 
Aortic VSM Cell Isolation  
Aortic VSM cells were isolated by enzymatic dissociation, as we do routinely.19 Briefly, 
aortas from WT and SMKO mice were removed, flushed with cold PBS supplemented 
with 1% antibiotic-antimycotic (Anti-Anti; Gibco, Life Technologies), and cleaned of 
periaortic fat. Cleaned aortas were then washed in PBS and incubated at 37°C for 12 
minutes in 3 mg/mL collagenase II (Worthington) in serum-free DMEM. Adventitia was 
removed manually and preserved at 80°C until Western blot or quantitative reverse 
transcription polymerase chain reaction (qRT-PCR), analysis. The medial layer was 
further dissociated in 3 mg/mL collagenase and 1 mg/mL elastase at 37°C for 30 minutes 
with gentle agitation every 10 minutes. Cells were centrifuged and resuspended in 
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complete growth medium (DMEM, 1 g/L glucose supplemented with 10% FBS and 1% 
Anti-Anti) and used until passage 10.  
 
Quantitative RT-PCR on Aortic Extracts  
The mRNA expression of several genes of interest (SirT1 exon 4, AT1R, MMP2, MMP3, 
MMP9, MMP19, MYH11) in aortic and VSM extracts was assessed using standard 
procedures. Briefly, total RNA from aortas and VSM cells of WT and SMKO mice was 
extracted with Trizol (Life Technologies), followed by chloroform separation and 
isopropanol precipitation. After total RNA retrotranscription (High-Capacity RNA-to-
cDNA Kit; Applied Biosystems, Life Technologies), RNA expression of genes of interest 
was analyzed by quantitative RT-PCR with verified TaqMan assays multiplexed for b-
actin (AB750 instrument; Applied Biosystems). Relative mRNA quantitation was 
calculated by the ΔΔCt method, expressed as relative to controls and normalized by b-
actin, used as an endogenous control.  
 
VSM Cell and Aortic Lysate Immunoprecipitation and Western Blot  
VSM cells from WT and SMKO mice were cultured in DMEM containing 10% FBS and 
1% Anti-Anti in triplicate tissue culture– grade 10-cm dishes. VSM cells were dissolved 
in RIPA buffer (200 lL/1 mg tissue; Cell Signaling Technology) supplemented with 
protease inhibitor cocktail and trichostatin A (5 lmol/L), as appropriate. After brief 
sonication (10 seconds, 39, on ice), protein concentration was assessed using the Pierce 
BCA Protein Assay (Thermo Scientific), per the manufacturer’s instructions. For 
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immunoprecipitation studies, equal amounts of proteins were incubated overnight at 4°C 
with 2 lg of an anti–acetyl lysine antibody immobilized to agarose beads (ImmunoChem) 
with rotating agitation. Beads were then washed with PBS and 1% NP40 3 times before 
elution with Laemmli buffer and Western blotting. To confirm effective deletion of active 
SirT1 in VSM, whole aortas or media and adventitia, separately, from saline- and AngII-
treated WT and SMKO mice were manually disrupted with a glass–glass homogenizer on 
ice and dissolved in RIPA buffer, as described above. VSM cell or aortic lysates and 
immunoprecipitated proteins were resolved by SDS-PAGE (7.5% or 4% to 20% 
polyacrylamide gels) and transferred to PVDF membranes (100 V, 120 minutes). 
Membranes were blocked in 5% nonfat milk in 1% Tween- 20 in PBS (PBS-T) for 1 hour 
and incubated with 1 of the following antibodies overnight at 1:1000 dilution: SirT1 
(item ab110304; Abcam), SM22a (a kind gift from K.G.M.), p53 (item 2524; Cell 
Signaling Technologies), TIMP-1 (item ab38798; Abcam), galectin-3 (item ab53082, 
Abcam), VCAM-1 (item 14694; Cell Signaling Technologies), and b-actin (item A5441; 
Sigma-Aldrich). Membranes were then washed in PBS-T and incubated with peroxidase-
conjugated anti-mouse or antirabbit antibodies (Cell Signaling Technologies) and 
exposed to the chemiluminescent substrate ECL (GE Healthcare) to visualize protein 
bands. Protein band intensities were quantified with ImageJ (National Institutes of 
Health, www.nih.gov), averaging band intensities pertaining to the same experimental 
group.  
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In-Gel zymography 
 Whole aortas, from the aortic root to the common iliac bifurcation, were dissected from 
saline- or AngII-treated WT, SMKO, or SMTg mice (n=4 in each group) and cleaned of 
periaortic fat. Aortas were divided into 8 equal parts and cultured at 37°C in 50 lL 
DMEM overnight. In a subset of experiments, freshly prepared tempol (10 mmol/L) was 
added to DMEM. Aortas were then homogenized on ice with 100 lL lysis buffer (50 
mmol/L Tris, 10 mmol/L CaCl2, 150 mmol/L NaCl, 1% Triton X-100, 0.1% SDS, 0.5% 
Brij 35, 0.05% azide pH 7.4) and centrifuged at 16100 g for 15 minutes to obtain the 
protein supernatant. Protein content of the aortic lysates was determined with the BCA 
Protein Assay (Thermo Scientific), per the manufacturer’s instructions. Equal amounts of 
aortic proteins and corresponding cultured aortic medium from 4 aortic homogenates, 1 
from each experimental group for a total of 8 samples, were loaded into a 10% zymogram 
gel containing gelatin as MMP substrate (item 161-1167; Bio-Rad) after mixing with 
zymogram loading buffer (item161-0764; Bio-Rad). Protein separation was carried out in 
SDS-containing buffer for 5 hours at 4°C. SDS was then exchanged with Triton X-100 
for 30 minutes at room temperature by soaking the gels in zymogram renaturation buffer 
(item161-0765; Bio-Rad), which was then replaced by the zymogram development buffer 
(item 161- 0766; Bio-Rad) for 30 minutes at room temperature. After a second change of 
fresh development buffer, the gels were incubated for 2 days at 37°C and stained with 
0.5% Coomassie Brilliant Blue R-250 (item 161-0400; Bio-Rad) dissolved in 40% 
methanol and 10% acetic acid for 1 hour. Gels were then destained with 20% methanol 
and 5% acetic acid. Gel images were captured by transillumination with a scanner 
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(Perfection 4990 Photo; Epson) at 48-bit color and 300-dpi resolution. White bright 
bands over a blue background were indicative of gelatin in-gel digestion by the 
enzymatic activity of MMPs.  
 
Oxidant Measurement by Dihydroethidine  
Dihydroethidine (DHE) was used to assess oxidant levels in VSM cells and fresh frozen 
aortic sections. In the presence of oxidants, mainly superoxide anion, DHE is oxidized to 
ethidium, which intercalates with nuclear DNA generating a red fluorescent signal. DHE 
solution (10 mmol/L) was freshly prepared in DMSO and diluted to 10 lmol/L working 
solution in PBS. Tiron, a superoxide scavenger, was freshly prepared at 10 mmol/L 
working solution (pH 7.4) and used to confirm the specificity of DHE fluorescence 
signal. Aortas from saline- or AngII-treated WT and SMKO mice were frozen in optimal 
cutting temperature compound and kept at 80°C until sectioning in a cryotome at a 
thickness of 10 lm. Aortic sections were washed on ice with cold PBS and incubated with 
DHE solution at 37°C for 45 minutes. A sequential section from the same aorta was 
positioned onto the same slide so that a tiron treatment (10 mmol/L, pH 7.4) could be run 
in parallel. Sections were then washed in PBS and coverslipped with Prolong Gold 
Antifade mounting medium (Life Technologies). Digital images were captured with an 
epifluorescent microscope (Nikon Eclipse 80i), a CDD camera (DQ Qi Mc), and NIS-
Elements 3.22 software (Nikon) and scored for red fluorescence intensity by 4 
independent observers, blinded to the experimental groups. Scores pertaining to the same 
experimental group were averaged (n=7, WT/ saline; n=5, SMKO/saline; n=5,  
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WT/AngII; n=12, SMKO/ AngII). VSM cells were obtained from WT and SMKO aortas, 
as described above, cultured in triplicate 10-cm culture dishes to 80% confluence and 
serum-starved overnight before treatment with AngII (100 nmol/L, 6 hours) or vehicle 
(PBS) in the presence of DHE or DHE plus tiron. At the end of the treatment period, 
VSM cells were washed in Hanks’ balanced salt solution, trypsinized, and analyzed by 
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flow cytometry with the assistance of the Boston University Analytical Core (LSRII Flow 
Cytometer; BD Biosciences).  
 
Inflammatory Cell Quantitation by Flow Cytometry  
 
Methods for quantitation of inflammatory cells in the aorta were adapted from Moore et 
al.20 Briefly, nondissected thoracic aortas from AngII-treated WT (n=5) and SMKO (n=4) 
mice were isolated and manually minced with fine scissors. Aortas were enzymatically 
digested for 40 minutes at 37°C under gentle agitation with a mixture of collagenases 
type IX and type I-S and hyaluronidase I-S dissolved in PBS containing Ca++ and Mg++. 
Cell debris and undigested material were removed by passing the suspension though a 
70-lm cell strainer. Subsequently, 1 million cells from each digested aorta were incubated 
with fluorescently conjugated CD45 and CD11b antibodies or isotype controls 
(Biolegend) in PBS containing 5% BSA for 25 minutes at 4°C, washed, and immediately 
analyzed by flow cytometry (LSRII Flow Cytometer, Boston University Flow Cytometry 
Core). Data are expressed as the average of percentage of CD45+ CD11b+ cells from 
triplicate experiments.  
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Echocardiography to Assess Left Ventricular Function  
 
Cardiac function of WT (n=4) and SMKO (n=5) mice aged 8 weeks was assessed by 
echocardiography (VisualSonics Vevo770, Toronto, Canada). Mice were lightly 
anesthetized with isofluorane/O2 to keep heart rates in the range of 400 to 500 beats per 
minute. Left ventricular ejection fraction and fractional shortening were measured with 
the left ventricular wall trace measurement tool (Vevo770 v3.0 software; VisualSonics) 
from M-mode images acquired from a left parasternal short-axis view at the level of the 
papillary muscles. 
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Statistical Analysis  
All data are expressed as meanSEM and analyzed by Student t test or by 1-way ANOVA 
to compare means of controls and experimental groups. If data were not normally 
distributed, Kruskal–Wallis with Dunn’s multiple comparisons post test was used. 
Repeated measures of blood pressure over time were analyzed by 1-way ANOVA with 
Dunnett’s multiple comparisons post hoc test. Kaplan–Meier survival curves with 
Wilcoxon post hoc test were used to assess the mortality of mice in different 
experimental groups. One-sided Wilcoxon rank-sum test was used to analyze dispersion 
of elastin by multiphoton autofluorescence. P values < 0.05 were considered significant. 
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Results  
AngII-Treated VSM SMKO Mice Die of Aortic Dissection  
To evaluate the role of VSM SirT1 in AngII-induced aortic remodeling, we generated a 
mouse with a SirT1 exon 4 deletion specifically in VSM (SMKO) and confirmed the 
deletion of functional SirT1 using both quantitative RT-PCR and Western blot of aortic 
media, adventitia, and cultured aortic VSM cells. Consistent with previous reports in 
other tissues,21,22 we found that SirT1 mRNA was decreased by 99% in aorta of SMKO 
mice compared with WT mice (Figure 1A). SMKO aortic media produced a truncated 
SirT1 protein with an apparent molecular mass 7 kDa lower than WT SirT1 that lacked 
the functional deacetylase domain (Figure 1B). We further confirmed the deletion in 
smooth muscle of aorta and other vessels, but not in the parenchyma of major organs, by 
intercrossing SM22a-Cre with a Tomato reporter mouse (Figure 2). Adventitial 
fibroblasts may acquire a myofibroblast (SM22a+ ) phenotype in response to increased 
aortic wall stresses because the adventitia becomes a major load-bearing component of 
the arterial wall under high pressures. Although the truncated SirT1 protein was not 
present in the adventitia of SMKO mice, we explored the possibility that, in response to 
AngII, SM22a+ myofibroblast might start expressing Cre-recombinase, resulting in SirT1 
deletion in adventitia; however, neither SM22a nor the exon 4–deleted SirT1 variant were 
detected in the adventitia after AngII in SMKO mice, confirming the deletion for the 
aortic media (Figure 3A). In addition, although SM22a expression is restricted to smooth 
muscle lineage during late embryonic stages and throughout adulthood, SM22a could be 
expressed in cardiac myocytes during early embryogenesis.23 SMKO mice, however, had 
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cardiac ejection fractions and fractional shortenings (assessed by echocardiography) and 
heart weight/tibia length ratios (Figure 3B) and heart rates comparable to WT littermates, 
indicating a normal cardiac phenotype. To confirm a decrease in SirT1 deacetylase 
activity in our novel mouse strain, we assessed the levels of acetylated p53, a 
proapoptotic transcription factor with activity inhibited by SirT1-mediated 
deacetylation.21 Acetylated p53 was significantly increased in VSM cells from SMKO 
aortas compared with WT (Figure 3C), consistent with decreased SirT1 activity in VSM 
of our novel murine model. To evaluate the role of VSM SirT1 in aortic remodeling, a 
hypertensive dose of AngII (1 mg/kg per day) was administered to WT and SMKO mice 
for 14 days using osmotic minipumps. AngII strikingly increased mortality in SMKO 
mice beginning as early as day 5 of treatment, with 50% of mice dying within 9 days and 
only 30% surviving until day 14 (Figure 4A). On necropsy, mice that spontaneously died 
or required euthanasia had blood in either the thoracic or abdominal cavity. Thrombosis 
was evident in the aortic wall in the thoracic or abdominal region and, in some cases, in 
both regions (Figure 4B and 4C). Considering that hypertension is a major risk factor for 
an aortic dissection,24 we determined whether SMKO mice had an exaggerated 
hypertensive response to AngII by monitoring the development of AngII-induced 
hypertension with radiotelemeters. Although WT and SMKO mice have similar baseline 
systolic, mean, and diastolic blood pressures (Figure 5A) and heart rates (Figure 5B), the 
hypertensive response to AngII was significantly attenuated in SMKO mice (Figure 5A). 
In an attempt to explain the blunted hypertensive response to AngII in SMKO, and 
because it has been reported previously that SirT1 regulates AT1R expression in cultured 
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VSM cells,25 we analyzed AT1R mRNA levels in aortas and mesenteric arteries by 
quantitative RT-PCR. At baseline, there was no difference in AT1R mRNA between WT 
and SMKO; however, AngII increased AT1R mRNA in WT but not in SMKO arteries, 
suggesting that the lower hypertensive response to AngII in SMKO mice may be due to 
decreased expression of AT1R (Figure 5C and 5D). We further characterized the pressure 
response to other vasoconstrictors using high-fidelity pressure catheters inserted into the 
carotid artery of anesthetized mice. Baseline mean arterial pressure and the pressure 
response to an intravenous bolus of phenylephrine (100 lL, 1 mmol/L) were comparable 
in WT and SMKO littermates (Figure 5E), suggesting that SirT1 deficiency in VSM does 
not induce a generalized effect on vasopressor responses. Moreover, the dramatic 
incidence of aortic dissection in SMKO mice given AngII was not a mere consequence of 
increased hemodynamic load on the aorta because an equipotent dose of norepinephrine 
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(10 mg/kg per day) increased blood pressure to the same extent as did AngII and in WT 
mice (Figure 5F), as measured by radiotelemetry, but failed to cause aortic dissections in 
any of SMKO mice (0 of 5).  
 
Structural and Mechanical Changes in SMKO Aorta in Response to AngII  
There was no apparent alteration in the number or organization of aortic elastic lamellae 
in SMKO aortas, excluding a developmental elastin defect in SMKO mice; however, 
following AngII, SMKO aortas showed disordered elastic lamellae with frequent elastin 
breaks (Figure 6A) and decreased medial hypertrophy (Table 1). An assessment of elastin 
microstructure by multiphoton microscopy16 at multiple locations along the aorta 
revealed typical parallel microstructure of elastin fibers in each elastic lamellae in SMKO 
mice at baseline, similar to WT littermates. After AngII, the elastin fiber network 
appeared disorganized in SMKO aortas and demonstrated significantly increased  
 
 
 
Table 1. 
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dispersion, indicative of fragmentation and disruption (Figure 6B and 6C). To evaluate 
the biomechanical properties of the aortic wall in WT and SMKO aortas, with and 
without AngII, we used an ex vivo measure of arterial stiffness in viable aortic rings from 
segments of the aorta that had no apparent dissection. Baseline arterial stiffness did not 
differ between SMKO and WT mice but was significantly increased after 5 days of AngII 
in SMKO aortas (Figure 7A), as expected in aortas with disorganized elastin.26 Consistent 
with ex vivo measurements, pulse wave velocity—an in vivo index of arterial stiffness 
measured in anesthetized mice at a comparable range of mean arterial pressure—was 
significantly increased in SMKO mice treated with AngII for 5 days (Figure 7B).  
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Molecular Mechanisms of Aortic Dissection in AngII-Treated SMKO Mice  
 
To start understanding the molecular mechanisms by which VSM SirT1 deficiency may 
lead to elastin fragmentation and aortic dissection, we assessed the expression and 
activity of MMPs, major elastin-degrading enzymes in the extracellular matrix, on 
isolated aortic extracts after 5 days of AngII, before any deaths occurred. Among various 
MMPs tested (MMP2, MMP3, MMP9, MMP19), MMP2 and MMP9 mRNA expression 
in isolated VSM cell extracts were significantly higher in SMKO than WT extracts at 
baseline. In vitro treatment of VSM cells with AngII (100 nmol/L, 6 hours) increased 
MMP2 and MMP9 mRNA in both WT and SMKO extracts but to a significantly greater 
extent in SMKO (Figure 8A). In-gel zymography of whole aortic extracts showed a 
significant increase in activities of MMP2 and MMP9 in SMKO extracts, particularly 
when assessed in the medium of cultured aortas (Figure 8B, top panel). Increases in 
MMP2 and MMP9 did not occur in mice overexpressing SirT1 in VSM (SMTg) (Figure 
8B, bottom panel). Because oxidants play an important role in the response of the aortic 
wall to AngII and MMP activation, we measured ROS on freshly frozen aortic sections, 
which indicated greater oxidant production in aortas of AngII-treated SMKO mice 
compared with AngII-treated WT mice (Figure 9A and quantitation in graph). Similarly, 
lack of SirT1 in VSM enhanced AngII-induced oxidant production in cultured VSM 
cells, as assessed by flow cytometry (Figure 9B). Incubation of cultured aortas with 
tempol (10 mmol/L), an oxidant scavenger, completely prevented AngII-induced MMP 
activation (Figure 9C). Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an 
endogenous inhibitor of MMP activity and is regulated by SirT1 in lung fibroblasts.27 
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TIMP-1 expression was impaired in SMKO aortas in both saline- and AngII-treated mice 
compared with WT aortas (Figure 9D and quantitation in graph). 
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Inflammatory cells that are resident or recruited in the aortic wall in response to AngII 
may contribute to increased oxidant production and MMP activity, leading to aortic 
dissection. After 5 days of AngII, SMKO aortas had numbers of CD45+ CD11b+ cells, 
assessed by flow cytometry (Figure 10A), and expression of the macrophage marker 
galectin- 3 and the adhesion molecule VCAM-1 (Figure 10B) comparable to WT 
littermates.  
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Discussion  
 
SirT1 is an evolutionarily conserved enzyme that deacetylates multiple intracellular 
targets and is important for a variety of cellular functions such as DNA damage repair, 
cell cycle regulation, apoptosis, senescence, and adaptation to metabolic stress. In the 
present study, we investigated the role of endogenous SirT1 in VSM during AngII 
infusion, using a novel mouse model lacking functional SirT1 in VSM (SMKO). We 
found that aortas lacking SirT1 in smooth muscle cells, although structurally and 
functionally not different from WT littermates at baseline, were prone to aortic 
dissections after modest doses of AngII (1 mg/kg per day), with only 30% of SMKO 
mice surviving a 14-day AngII treatment. In SMKO mice, blood pressures at baseline and 
after a-adrenergic agonists were not different than those in WT mice, indicating that lack 
of SirT1 in VSM does not affect peripheral vascular resistance or a-adrenergic 
vasoconstriction responses. Nonetheless, after even brief exposure to AngII (5 days), 
42% (24 of 56) of the SMKO mice were alive but with dissected aortas. This was 
associated with increased oxidant production and MMP activities, leading to severe 
elastin fragmentation compared with WT. Our findings strongly implicate a requirement 
of the aortic wall for VSM SirT1 to maintain structural and functional integrity and to 
prevent aortic dissection by preventing matrix metalloproteinase activation and elastin 
fragmentation. Notably, AngII-induced aortic dissections in SMKO mice were not a mere 
consequence of increased hemodynamic stress on the aortic wall because (1) AngII-
induced hypertension was blunted in SMKO mice compared with WT mice and (2) a 
hypertensive dose of norepinephrine—a vasoconstrictor that, compared with AngII, does 
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not induce inflammation and oxidant production in the vasculature28—did not cause 
aortic dissections despite systolic blood pressure increases similar to those caused by 
AngII in the SMKO mice. A blunted hypertensive response of SMKO mice to AngII 
appears to be due to a failure of SMKO arteries to upregulate AT1R in response to AngII 
infusion (Figure 5C and 5D). A recent study demonstrated involvement of SirT1 in AT1R 
promoter regulation using cultured VSM cells,25 but the mechanisms by which SirT1 
regulates AT1R in vivo warrant further investigation. In our study, MMP activation in 
response to AngII was prevented in mice overexpressing SirT1 in VSM, pointing to 
MMP as a VSM SirT1 downstream target and the cause of elastolysis and aortic 
dissection. SirT1 negatively regulates MMP gene transcription and activity via multiple 
mechanisms, namely, by deacetylating nuclear factor jB 29,30 and TIMP-1,27 an 
endogenous MMP antagonist. Both saline- and AngIItreated aortas of SMKO mice had 
significantly lower TIMP-1 protein expression compared with WT mice (Figure 9D). In 
addition, MMPs are posttranscriptionally activated by ROS, mainly by glutathionylation 
of cysteine residues in the active site.31 SirT1 deficiency in VSM was associated with 
increased ROS production, as assessed in AngII-treated SMKO VSM cells and aortic 
sections (Figure 9A and 9B). This is consistent with the fact that SirT1 boosts the cellular 
antioxidant capacity by directly stimulating nuclear factor E2-related factor 2,32 a 
transcription factor that induces the expression of 2 potent oxidant-scavenging enzymes 
(hemoxygenase-1 and superoxide dismutase), and by modulating FOXO and p66shc.8,33 
To the extent that MMPs are activated by ROS, excessive ROS on AngII infusion and in 
settings of SirT1 deficiency might also have contributed to MMP activation in SMKO 
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aortas, as corroborated by the fact that tempol (an oxidant scavenger) was able to 
completely prevent AngIIinduced MMP activation (Figure 9C). Notably, although 
structurally normal at baseline, SMKO aortas are primed for activation of MMPs, as 
indicated by an increase in baseline MMP mRNA expression and oxidants. It is likely 
that SirT1 regulates multiple factors responsible for alterations in MMP mRNA and 
protein expression, oxidant production, and scavenging and for MMP activity responsible 
for elastin breakdown, increased stiffness, and dissection of the aorta, despite lower blood 
pressure. Considering that activation and infiltration of inflammatory cells in the aorta is 
a hallmark of this model of AngII hypertension,34 we cannot exclude a contribution of 
inflammatory cells to oxidant production and MMP activation in aortas of AngII-treated 
mice; however, our study indicated that the exaggerated oxidant production and MMP 
activities in SMKO aortas leading to aortic dissection are not due to increased 
recruitment of inflammatory cells in aortas lacking VSM SirT1 compared with WT aortas 
after AngII. Aortic dissection is a life-threatening condition for which treatment options 
are currently limited. Our study demonstrates that VSM SirT1 is a crucial requirement for 
vessel integrity and for preventing aortic dissection in settings of AngII hypertension. Of 
note, a recent study used the same VSM SirT1 knockout mice as ours and reported that 
the mice, when on an apolipoprotein E–null background and fed an atherogenic diet, 
were prone to atherosclerotic plaque formation to a greater extent than controls. 
Interestingly, in 2 of 12 mice studied, medial degeneration and elastin fragmentation were 
evident in atherosclerotic lesions and associated with aortic aneurysm and dissection.10 
Although the authors underscored that these pathological features were observed only in 
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16% of mice with apolipoprotein E deletion and concomitant fat feeding but not in 
controls, their data pointed to a broader protective role of VSM SirT1 against aortic 
media tearing and dissection. Furthermore, resveratrol, a natural polyphenol known to 
activate SirT1, has recently been shown to prevent arterial remodeling and stiffening in 
mice 35,36 and in nonhuman primates.37 Consequently, polyphenols and specific SirT1 
activators could be attractive therapeutic approaches against aortic dissections or rupture 
in patients at risk, such as hypertensive persons or those with Marfan’s syndrome and 
related disorders.  
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